Home Newsletter Honored Guests Blog About Us Work With Us Sponsor & Advertise Be a Guest The Production Suite Get the Briefing

Open Door Salon

Karla Loken

Karla Loken

Founder, Loken & Associates | OB-GYN & Women's Health Medical-Affairs Leader

Dr. Karla Loken is a physician and women’s-health leader who founded Loken & Associates, a medical-affairs consultancy. An osteopathic OB-GYN (DO, FACOOG), she practiced and cared for patients for more than two decades before moving to the industry side of medicine, where she has held senior clinical-development, safety, and medical-affairs roles spanning medical devices, diagnostics, and pharmaceuticals, including at Hologic, FEMSelect, and HerMD.

Loken is also a longtime women’s-health and vaccine advocate. She lost her sister to meningitis at sixteen and has campaigned for vaccines and disease prevention throughout her career, and she works on women’s-health advocacy and fundraising nationally.

Loken appeared on Open Door Salon twice. She first joined a conversation with pharmacist and patient advocate Tina Valbh on the gaps patients fall through, where she argued that medicine’s silos leave no unified source of truth and that industry “patient journey” maps miss most of the touchpoints because patients are never consulted. She returned for a one-on-one conversation after being diagnosed with a rare appendiceal cancer, going public with her diagnosis to help others.

As both a physician and a patient, Loken’s recurring theme was access. She described how her medical training, physician spouse, and industry network connected her to expert second opinions within hours, then named the survivor’s guilt of knowing the average patient has none of that. No one fits a cookbook, she argued: every patient becomes an “N of one,” and what the system most needs is more navigators to translate complex medicine into terms patients can act on.

On Open Door Salon

“"I'm Lucky I Had the Network" — A Physician Becomes a Cancer Patient”
Dr. Karla Loken · April 1, 2026

Episode page & show notes on Open Door Salon

“We work in these silos, and there's no unified source of information. The family physician trying to coordinate all the care never really gets to talk to the expert and see things from start to finish.”Karla Loken, on Open Door Salon (on fragmented care)
“I had so many resources available to me as a physician and in industry, and it hit me hard that the average person doesn't have this connectivity. How do we fix this?”Karla Loken, on Open Door Salon (on the access gap she saw as a patient)
“No one fits exactly into a cookbook. Each of us brings our own family history, genetic risk, and past medical history, so you become an N of one.”Karla Loken, on Open Door Salon (on individualized cancer care, as physician and patient)

In this episode

  • Medicine's silos: no unified source of truth
  • Why "patient journey" maps miss most of the touchpoints
  • Fighting TikTok and Google misinformation in the exam room
  • "I'm lucky I had the network": a physician becomes a cancer patient
  • Going public with a rare appendiceal-cancer diagnosis
  • The survivor's guilt of having connections most patients lack
  • Every patient is an "N of one" — no cookbook
  • What the system needs most: more patient navigators
  • Advocating for women's health and vaccines

Topics

Women's HealthObstetrics & GynecologyMedical AffairsClinical DevelopmentMedical Devices & DiagnosticsPatient AdvocacyVaccinesCancer SurvivorshipHealthcare NavigationPhysician-as-Patient

Watch on Open Door Salon

We Mapped the Patient Journey. No You Didn't | Tina Valbh & Karla Loken
"I'm Lucky I Had the Network" — A Physician Becomes a Cancer Patient | Dr. Karla Loken

Open Door Salon brings life-sciences leaders into candid conversation. Every Monday, the week's takeaways land in your inbox.

Subscribe on Substack →
The Briefing

Need the life-sciences signal but short on time?

Get a free quarterly briefing: four pages on what life-sciences operators are actually saying about Biosecure, AI hype vs. substance, and the $50,000 cell-therapy question. Ten minutes, in your inbox.